Study on clinical characteristics and response of growth hormone(GH) during GH releasing peptide (GHRP)-2 test in patients with non-functioning pituitary adenomas

Study on clinical characteristics and response of growth hormone(GH) during GH releasing peptide (GHRP)-2 test in patients with non-functioning pituitary adenomas - Study on clinical characteristics and response of growth hormone(GH) during GH releasing peptide (GHRP)-2 test in patients with non-functioning pituitary adenomas

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035557

Enrollment

Registered

2019-01-31

Start date

2019-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult growth hormone deficiency (AGHD)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 76 patients who were underwent transsphenoidal surgery at Nippon Medical School Hospital between October 2012 and November 2017.

Exclusion criteria

Exclusion criteria: Patients who had a history of previous transsphenoidal surgery were excluded from the study.

Design outcomes

Primary

Measure	Time frame
Clarification of the difference between clinical characteristics and response of growth hormone(GH) during GH releasing peptide (GHRP)-2 test in patients with non-functioning pituitary adenomas.	—

Countries

Japan

Contacts

Public ContactIzumi Fukuda

Nippon Medical School Hospital Department of Endocrinology, Diabetes and Metabolism

i-fukuda@nms.ac.jp03-3822-2131

Outcome results